{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:51:31Z","timestamp":1794966691587,"version":"4.9.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Tissue diagnosis is essential in the usual management of high-grade glioma. In rare circumstances, due to patient preference, performance status, comorbidities, or tumor location, biopsy is not feasible. Sometimes a biopsy is nondiagnostic. Many neuro-oncology clinics have patients like this, but these patients\u2019 outcomes and responses to treatment are not known.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively reviewed records from adult patients diagnosed with presumed high-grade glioma of the brain without definitive pathology, diagnosed between 2004 and 2016. We recorded several clinical variables including date of first diagnostic imaging and date of death.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 61 patients and subclassified them to brainstem glioma (n\u2005=\u200532), supratentorial presumed glioblastoma (n\u2005=\u200524), presumed thalamic diffuse midline glioma (n\u2005=\u20052), gliomatosis cerebri (n\u2005=\u20052), and cerebellar glioma (n\u2005=\u20051). Most brainstem glioma patients had no biopsy because of tumor location. Supratentorial presumed glioblastoma patients had no biopsy predominantly because of comorbidities. Median survival, from first diagnostic imaging, was 3.2 months (95% CI: 2.9 to 6.3 months) in the supratentorial glioblastoma group and 18.5 months (95% CI: 13.0 to 44.1 months) in the brainstem group. Treatment with radiation or chemotherapy did not alter the median survival of the supratentorial glioblastoma group (hazard ratio 1.41, uncorrected P\u2005=\u2005.5).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with imaging diagnoses of high-grade glioma have similar, if not worse, survival than those with pathological confirmation. Based on these uncontrolled data, it is unclear how effective radiation or chemotherapy is in this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/nop\/npaa009","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T02:37:33Z","timestamp":1584326253000},"page":"446-452","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes of presumed malignant glioma treated without pathological confirmation: a retrospective, single-center analysis"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4961-237X","authenticated-orcid":false,"given":"Seth Andrew","family":"Climans","sequence":"first","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Cepe","family":"Ramos","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8930-9650","authenticated-orcid":false,"given":"Normand","family":"Laperriere","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Toronto Western Hospital, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren P","family":"Mason","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"key":"2020120619104367700_CIT0001","author":"National Comprehensive Cancer Network.","year":"2019"},{"key":"2020120619104367700_CIT0002","first-page":"664","article-title":"The therapy of unbiopsied brain tumors","volume":"93","author":"Sheline","year":"1965","journal-title":"Am J Roentgenol Radium Ther Nucl Med."},{"issue":"2","key":"2020120619104367700_CIT0003","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1148\/93.2.413","article-title":"Radiation therapy of brain-stem tumors","volume":"93","author":"Whyte","year":"1969","journal-title":"Radiology."},{"issue":"1","key":"2020120619104367700_CIT0004","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3171\/jns.1975.43.1.0065","article-title":"Radiation of infratentorial and supratentorial brain-stem tumors","volume":"43","author":"Lee","year":"1975","journal-title":"J Neurosurg."},{"issue":"11","key":"2020120619104367700_CIT0005","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/1097-0142(19890601)63:11<2124::AID-CNCR2820631109>3.0.CO;2-9","article-title":"Prognostic factors and results of therapy for adult thalamic and brainstem tumors","volume":"63","author":"Grigsby","year":"1989","journal-title":"Cancer."},{"issue":"8","key":"2020120619104367700_CIT0006","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jocn.2013.12.011","article-title":"Prognostic factors and survival in primary adult high grade brainstem astrocytoma: a population based study from 1973-2008","volume":"21","author":"Dey","year":"2014","journal-title":"J Clin Neurosci."},{"issue":"4","key":"2020120619104367700_CIT0007","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0360-3016(92)90704-L","article-title":"Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults","volume":"24","author":"Shrieve","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"2020120619104367700_CIT0008","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/radiology.209.1.9769815","article-title":"Focal brain lesions: effect of single-voxel proton MR spectroscopic findings on treatment decisions","volume":"209","author":"Adamson","year":"1998","journal-title":"Radiology."},{"issue":"2","key":"2020120619104367700_CIT0009","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11060-008-9545-1","article-title":"Prognostic factors in adult brainstem gliomas: a multicenter, retrospective analysis of 101 cases","volume":"88","author":"Kesari","year":"2008","journal-title":"J Neurooncol."},{"issue":"2","key":"2020120619104367700_CIT0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00415-008-0589-0","article-title":"Natural history and management of brainstem gliomas in adults. A retrospective Italian study","volume":"255","author":"Salmaggi","year":"2008","journal-title":"J Neurol."},{"issue":"3","key":"2020120619104367700_CIT0011","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11060-014-1589-9","article-title":"Temozolomide after radiotherapy in recurrent \u201clow grade\u201d diffuse brainstem glioma in adults","volume":"120","author":"Reyes-Botero","year":"2014","journal-title":"J Neurooncol."},{"key":"2020120619104367700_CIT0012","volume-title":"R: A Language and Environment for Statistical Computing [computer program]","author":"R Core Team.","year":"2018"},{"key":"2020120619104367700_CIT0013","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro-Oncol."},{"issue":"10","key":"2020120619104367700_CIT0014","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"issue":"22","key":"2020120619104367700_CIT0015","first-page":"2197","article-title":"Radiation plus temozolomide in patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N Engl J Med."},{"issue":"5","key":"2020120619104367700_CIT0016","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3171\/2011.7.JNS101238","article-title":"Low-grade gliomas in adults","volume":"115","author":"Sanai","year":"2011","journal-title":"J Neurosurg."},{"issue":"1","key":"2020120619104367700_CIT0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11060-019-03287-9","article-title":"Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?","volume":"145","author":"El-Khouly","year":"2019","journal-title":"J Neurooncol."},{"issue":"pt 12","key":"2020120619104367700_CIT0018","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1093\/brain\/124.12.2528","article-title":"Brainstem gliomas in adults: prognostic factors and classification","volume":"124","author":"Guillamo","year":"2001","journal-title":"Brain."}],"container-title":["Neuro-Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nop\/advance-article-pdf\/doi\/10.1093\/nop\/npaa009\/32906992\/npaa009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nop\/article-pdf\/7\/4\/446\/34551187\/npaa009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nop\/article-pdf\/7\/4\/446\/34551187\/npaa009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T01:24:07Z","timestamp":1607304247000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nop\/article\/7\/4\/446\/5805485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,3,16]]},"published-print":{"date-parts":[[2020,7,31]]}},"URL":"https:\/\/doi.org\/10.1093\/nop\/npaa009","relation":{},"ISSN":["2054-2577","2054-2585"],"issn-type":[{"value":"2054-2577","type":"print"},{"value":"2054-2585","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,3,16]]}}}